Published in Blood Weekly, July 28th, 1997
These cells have great potential in clinical gene therapy, said Raji Shankar, University of Minnesota Medical School, Minneapolis, Minnesota, and colleagues ("Retroviral Transduction of Peripheral Blood Leukocytes in a Hollow-Fiber Bioreactor," Transfusion, July 1997;37:685-690).
They noted that other researchers have used hollow-fiber...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.